These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 28613199

  • 1. Efficacy of 18F-2-fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computerized Tomography for Bone Marrow Infiltration Assessment in the Initial Staging of Lymphoma.
    Öner AO, Sürer Budak E, Aydın F, Salim O, Yücel OK, Akkaya B, Toptaş T, Boz A, Yıldız A, Güngör F, Undar L.
    Mol Imaging Radionucl Ther; 2017 Jun 01; 26(2):69-75. PubMed ID: 28613199
    [Abstract] [Full Text] [Related]

  • 2. 18F-FDG PET-CT imaging versus bone marrow biopsy in pediatric Hodgkin's lymphoma: a quantitative assessment of marrow uptake and novel insights into clinical implications of marrow involvement.
    Hassan A, Siddique M, Bashir H, Riaz S, Wali R, Mahreen A, Nawaz MK.
    Eur J Nucl Med Mol Imaging; 2017 Jul 01; 44(7):1198-1206. PubMed ID: 28229191
    [Abstract] [Full Text] [Related]

  • 3. Utility of 18F-fluorodeoxyglucose PET-CT scan in detecting bone marrow involvement in lymphoma.
    Jitani AK, Dutta S, Mandal PK, De R, Jajodia E, Baul S, Chakrabarti P, Dolai TK.
    Indian J Med Res; 2021 May 01; 154(5):691-698. PubMed ID: 35532587
    [Abstract] [Full Text] [Related]

  • 4. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
    Ngeow JYY, Quek RHH, Ng DCE, Hee SW, Tao M, Lim LC, Tan YH, Lim ST.
    Ann Oncol; 2009 Sep 01; 20(9):1543-1547. PubMed ID: 19474116
    [Abstract] [Full Text] [Related]

  • 5. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G, Çıkrıkçıoğlu MA, Özkan T, Karatoprak C, Ar MC, Eşkazan AE, Ayer M, Cerit A, Gözübenli K, Uysal BB, Erdem S, Ergül N, Tatar G, Çermik TF.
    Turk J Haematol; 2015 Sep 01; 32(3):213-9. PubMed ID: 25912844
    [Abstract] [Full Text] [Related]

  • 6. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases.
    Büyükşimşek M, Kolsuz İ, Yetişir AE, Tohumcuoğlu M, Oğul A, Mirili C, Paydaş S, Güney İB.
    Turk J Haematol; 2020 Nov 19; 37(4):220-225. PubMed ID: 32003552
    [Abstract] [Full Text] [Related]

  • 7. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E, Penna D, Deandreis D, Chiappella A, Skanjeti A, Vitolo U, Bisi G.
    Q J Nucl Med Mol Imaging; 2008 Mar 19; 52(1):9-16. PubMed ID: 18235420
    [Abstract] [Full Text] [Related]

  • 8. Role of 2-(fluorine-18) Fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography in Initial Staging and Bone Marrow Involvement Prediction in Patients with Newly Diagnosed Lymphoma in Correlation with Bone Marrow Study.
    Krishna S, Ravina M, Nanda S, Lukose TT, Moideen A, Bansal H, Dasgupta S, Kote R.
    Indian J Nucl Med; 2024 Mar 19; 39(1):10-17. PubMed ID: 38817719
    [Abstract] [Full Text] [Related]

  • 9. Diagnostic performance of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography in identifying bone marrow infiltration in new patients with diffuse large B-cell lymphoma and Hodgkin lymphoma.
    Kandeel AA, Hussein M, Zidan L, Younis J, Edesa W, Alsayed Y.
    Nucl Med Commun; 2020 Mar 19; 41(3):269-279. PubMed ID: 31895758
    [Abstract] [Full Text] [Related]

  • 10. Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Acta Radiol; 2015 Oct 19; 56(10):1230-5. PubMed ID: 25387723
    [Abstract] [Full Text] [Related]

  • 11. Exploring the role of FDG-PET in the assessment of bone marrow involvement in lymphoma patients as interpreted by qualitative and semiquantitative disease metabolic activity parameter.
    Kand PG, Tiwari BP, Basu S, Asopa RV, Nayak UN.
    Indian J Cancer; 2010 Oct 19; 47(4):380-4. PubMed ID: 21131749
    [Abstract] [Full Text] [Related]

  • 12. Role of F-18 FDG PET/CT in assessing bone marrow involvement in pediatric Hodgkin's lymphoma.
    Agrawal K, Mittal BR, Bansal D, Varma N, Srinivasan R, Trehan A, Manohar K, Kashyap R, Bhattacharya A, Marwaha RK.
    Ann Nucl Med; 2013 Feb 19; 27(2):146-51. PubMed ID: 23143537
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Ann Nucl Med; 2015 Feb 19; 29(2):132-7. PubMed ID: 25348549
    [Abstract] [Full Text] [Related]

  • 14. Comparison of bone marrow biopsy and fluorodeoxyglucose-positron emission tomography for the assessment of bone marrow infiltration in children with Hodgkin's lymphoma.
    Arslantaş E, Ayçiçek A, Akıcı F, Özkara S, Yılmaz B, Özdemir N, Bayram C.
    Nuklearmedizin; 2023 Feb 19; 62(1):20-26. PubMed ID: 36746148
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Am J Hematol; 2014 Jul 19; 89(7):726-31. PubMed ID: 24711255
    [Abstract] [Full Text] [Related]

  • 16. Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.
    Balbo-Mussetto A, Saviolo C, Fornari A, Gottardi D, Petracchini M, Macera A, Lario CV, Gallo T, Tarella C, Cirillo S.
    Radiol Med; 2017 Aug 19; 122(8):623-632. PubMed ID: 28421406
    [Abstract] [Full Text] [Related]

  • 17. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy.
    Teagle AR, Barton H, Charles-Edwards E, Dizdarevic S, Chevassut T.
    Acta Radiol; 2017 Dec 19; 58(12):1476-1484. PubMed ID: 28382828
    [Abstract] [Full Text] [Related]

  • 18. The Value of 18F-FDG PET/CT in Detecting Bone Marrow Involvement in Childhood Cancers.
    Yağci-Küpeli B, Koçyiğit-Deveci E, Adamhasan F, Küpeli S.
    J Pediatr Hematol Oncol; 2019 Aug 19; 41(6):438-441. PubMed ID: 31033787
    [Abstract] [Full Text] [Related]

  • 19. Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.
    Cheng G, Chen W, Chamroonrat W, Torigian DA, Zhuang H, Alavi A.
    Eur J Nucl Med Mol Imaging; 2011 Aug 19; 38(8):1469-76. PubMed ID: 21505896
    [Abstract] [Full Text] [Related]

  • 20. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Aug 19; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.